There are a few small (and I do mean small) studies out there that claim to demonstrate some benefit in bipolar disorder for patients who were non-responders to lithium and depakote, mostly in reduction of manic symptoms. This is the most interesting one: Donepezil in treatment-resistant bipolar disorder - ScienceDirect . It seems like not an absolutely insane third or fourth-line treatment approach for the sort of bipolar folks who have been depressed like once ever and mostly get manic on a very regular basis. Probably not at all useful for the sort of bipolar folks who got hypomanic/manic like once ever and mostly get depressed on a very regular basis. Can't find any similar data for aricept.
So basically either the person prescribing this is someone with a very deep knowledge of essentially speculative approaches to managing treatment-resistant bipolar disorder, or they are a muppet as whopper suggests.
I was just doing a lit review as you posted. I found a recent meta-analysis that found no effect of Aricept, galantamine, or memantine in Bipolar
Acetylcholinesterase inhibitors and memantine in bipolar disorder: A systematic review and best evidence synthesis of the efficacy and safety for multiple disease dimensions - ScienceDirect
Also, some possibility (albeit scant evidence) of donepezil induced mania in AD patients going through up-titration
Donepezil-associated manic episode with psychotic features: a case report and review of the literature - ScienceDirect
I think it is safe to say that the evidence is far from overwhelming for this being a useful approach. That said, I am always sensitive to the notion that particular endophenotypes of ostensibly the same DSM disorder may actually have a significant benefit from a medication that is not shared by most people with the diagnosis, and so will be wiped out in most large samples. We see this with neuroleptics with a population of folks who kinda sorta maybe improve with them and don't separate all that well from placebo but then a group of 10% or so who get dramatically better. Of note if used indiscriminately this is also an excellent justification of all manner of quackery, and I recognize that, but unfortunately reality is messy and it is hard to formulate a deontologically satisfying rule here.
I totally get the whole idea that if a patient has not really been helped by the first several lines of treatment, it's generally ok to start strongly considering off label meds. But, from this person's med history, they were just started on a combo of donepezil, trileptal, and queitiapine from the get go following a bad manic episode.
Have never heard anything like this.
This sounds like one of those cases where it would be easier to pick up the phone and just ask the prescriber what their reason for prescribing Aricept was.
Which bring me to the next unacceptable yet commonly held thing going on. I get records less than half the time despite that federal law states they must be given if requested by the patient unless the institution is owed money by the patient or they have good reason to believe that by giving the notes it'll cause physical harm to someone else. So again if it turns out less than half are not doing the expected legal minimum, what opinion am I supposed to have?
Prescribers who took over after that apparently didn't feel like messing with the medications too much.
When I get other doctor's notes it's usually to the effect of "prescribe medication X 10 mg"
Then next note: "stop medication x" with no writing on the rationale or the effects the medication had on the patient.
That is also sad to hear. Surely if something doesn't make sense, it is the new treating doctor's responsibility to re-evaluate the suitability and effectiveness of all prescribed medication. One has to be aware of their limitations obviously, but if something was like Aricept was being prescribed at a low dose it wouldn't be difficult to reduce it or cease it, or if it was at a high dose to refer to a psychogeriatrician for a second opinion.
Have no idea how one could practice without documenting this kind of stuff!
It's the 10mg dose. And, this person isn't at the level of needing a psychogeriatrician yet, they're only 50! That's a young patient in my usual population.